glp 1 addiction studies GLP‑1 drugs may fight across every major substance, according to a study of 600,000 people GLP-1 Analogues in the Neurobiology

Silver IA, Erecinska M

Glucagon-Like Peptide-1 Analogues: An Overview

Restarting before this window closes means building on suppressed receptor sensitivity, which requires 20-30% higher doses for equivalent effect and accelerates tolerance development over multiple cycles

Acta Period Technol

"Natural equivalent" comparisons to prescription drugs, "clinically proven" claims without controlled studies, and outcome-based advertising ("see un-hunger") all face the same scrutiny regardless of who owns the brand

This contrasts with a previous study which was unable to detect vesicular co-localisation of VNUT with GLP-1 and concluded that the transporter might be restricted to small vesicles 12